Page last updated: 2024-10-26

valproic acid and Thrombotic Microangiopathies

valproic acid has been researched along with Thrombotic Microangiopathies in 1 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Thrombotic Microangiopathies: Diseases that result in THROMBOSIS in MICROVASCULATURE. The two most prominent diseases are PURPURA, THROMBOTIC THROMBOCYTOPENIC; and HEMOLYTIC-UREMIC SYNDROME. Multiple etiological factors include VASCULAR ENDOTHELIAL CELL damage due to SHIGA TOXIN; FACTOR H deficiency; and aberrant VON WILLEBRAND FACTOR formation.

Research Excerpts

ExcerptRelevanceReference
"An adolescent male with difficult to control epilepsy was admitted for impaired hepatic function while on valproic acid therapy."3.85Thrombotic microangiopathy associated with Valproic acid toxicity. ( Bohan, TP; Erikson, CL; Hebert, SA; Swinford, RD, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hebert, SA1
Bohan, TP1
Erikson, CL1
Swinford, RD1

Other Studies

1 other study available for valproic acid and Thrombotic Microangiopathies

ArticleYear
Thrombotic microangiopathy associated with Valproic acid toxicity.
    BMC nephrology, 2017, Aug-03, Volume: 18, Issue:1

    Topics: Adolescent; Anticonvulsants; Epilepsy; Humans; Male; Thrombotic Microangiopathies; Valproic Acid

2017